235 related articles for article (PubMed ID: 27117954)
1. The many faces of interleukin-17 in inflammatory skin diseases.
Speeckaert R; Lambert J; Grine L; Van Gele M; De Schepper S; van Geel N
Br J Dermatol; 2016 Nov; 175(5):892-901. PubMed ID: 27117954
[TBL] [Abstract][Full Text] [Related]
2. [Anxiety as a state and anxiety as a personality trait in patients with alopecia areata, rosacea and lichen ruber planus].
Puchalski Z; Szlendak L
Z Hautkr; 1983 Jul; 58(14):1038-48. PubMed ID: 6225253
[TBL] [Abstract][Full Text] [Related]
3. Aberrant inflammasome activation as a driving force of human autoimmune skin disease.
Fetter T; de Graaf DM; Claus I; Wenzel J
Front Immunol; 2023; 14():1190388. PubMed ID: 37325658
[TBL] [Abstract][Full Text] [Related]
4. Dissecting susceptibility from exogenous triggers: the model of alopecia areata and associated inflammatory skin diseases.
Garzorz N; Alsisi M; Todorova A; Atenhan A; Thomas J; Lauffer F; Ring J; Schmidt-Weber C; Biedermann T; Eyerich S; Eyerich K
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2429-35. PubMed ID: 26416203
[TBL] [Abstract][Full Text] [Related]
5. [Anxiety pattern in patients with alopecia areata, rosacea and lichen planus].
Puchalski Z
Przegl Dermatol; 1983; 70(5-6):521-6. PubMed ID: 6230698
[No Abstract] [Full Text] [Related]
6. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
Mitra A; Raychaudhuri SK; Raychaudhuri SP
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
[TBL] [Abstract][Full Text] [Related]
7. New insights into the pathogenesis of cutaneous autoimmune disorders.
Chiricozzi A; Zhang S; Dattola A; Cannizzaro MV; Gabellini M; Chimenti S; Nistico SP
J Biol Regul Homeost Agents; 2012; 26(2):165-70. PubMed ID: 22824743
[TBL] [Abstract][Full Text] [Related]
8. Psychosomatic dermatology.
Panconesi E
Clin Dermatol; 1984; 2(4):94-179. PubMed ID: 6242532
[No Abstract] [Full Text] [Related]
9. Stressful life events and skin diseases: disentangling evidence from myth.
Picardi A; Abeni D
Psychother Psychosom; 2001; 70(3):118-36. PubMed ID: 11340413
[TBL] [Abstract][Full Text] [Related]
10. MANAGEMENT OF THE PSYCHOGENIC FACTORS IN DERMATOSES BY USE OF CHEMOTHERAPY.
SEGAEL A; ROGIN JR
Med Times; 1964 Feb; 92():113-6. PubMed ID: 14127053
[No Abstract] [Full Text] [Related]
11. Role of sebaceous glands in inflammatory dermatoses.
Shi VY; Leo M; Hassoun L; Chahal DS; Maibach HI; Sivamani RK
J Am Acad Dermatol; 2015 Nov; 73(5):856-63. PubMed ID: 26386632
[TBL] [Abstract][Full Text] [Related]
12. Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus.
Martin JC; Baeten DL; Josien R
Clin Immunol; 2014 Sep; 154(1):1-12. PubMed ID: 24858580
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-17 in systemic lupus erythematosus: A comprehensive review.
Li D; Guo B; Wu H; Tan L; Chang C; Lu Q
Autoimmunity; 2015; 48(6):353-61. PubMed ID: 25894789
[TBL] [Abstract][Full Text] [Related]
14. Advances in the treatment of diseases of the skin.
Beare JM
Practitioner; 1971 Oct; 207(240):450-9. PubMed ID: 4257203
[No Abstract] [Full Text] [Related]
15. Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis.
Mudigonda P; Mudigonda T; Feneran AN; Alamdari HS; Sandoval L; Feldman SR
Dermatol Online J; 2012 Oct; 18(10):1. PubMed ID: 23122008
[TBL] [Abstract][Full Text] [Related]
16. GILZ regulates Th17 responses and restrains IL-17-mediated skin inflammation.
Jones SA; Perera DN; Fan H; Russ BE; Harris J; Morand EF
J Autoimmun; 2015 Jul; 61():73-80. PubMed ID: 26077873
[TBL] [Abstract][Full Text] [Related]
17. Are neutrophilic dermatoses autoinflammatory disorders?
Satoh TK; Mellett M; Contassot E; French LE
Br J Dermatol; 2018 Mar; 178(3):603-613. PubMed ID: 27905098
[TBL] [Abstract][Full Text] [Related]
18. [Cyclosporin A in the therapy of inflammatory dermatoses].
Peter RU; Ruzicka T
Hautarzt; 1992 Nov; 43(11):687-94. PubMed ID: 1468930
[TBL] [Abstract][Full Text] [Related]
19. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
Zhu S; Qian Y
Clin Sci (Lond); 2012 Jun; 122(11):487-511. PubMed ID: 22324470
[TBL] [Abstract][Full Text] [Related]
20. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
